Correlation Between Silverback Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Silverback Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silverback Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silverback Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Silverback Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silverback Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silverback Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Silverback Therapeutics and Lixte Biotechnology
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Silverback and Lixte is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Silverback Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Silverback Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silverback Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Silverback Therapeutics i.e., Silverback Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Silverback Therapeutics and Lixte Biotechnology
Given the investment horizon of 90 days Silverback Therapeutics is expected to under-perform the Lixte Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Silverback Therapeutics is 2.5 times less risky than Lixte Biotechnology. The stock trades about -0.01 of its potential returns per unit of risk. The Lixte Biotechnology Holdings is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 181.00 in Lixte Biotechnology Holdings on October 24, 2024 and sell it today you would earn a total of 52.00 from holding Lixte Biotechnology Holdings or generate 28.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silverback Therapeutics vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Silverback Therapeutics |
| Lixte Biotechnology |
Silverback Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silverback Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Silverback Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silverback Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Silverback Therapeutics vs. Nuvalent | Silverback Therapeutics vs. Arcellx | Silverback Therapeutics vs. Vaxcyte | Silverback Therapeutics vs. Crinetics Pharmaceuticals |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |